These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35763396)

  • 1. Calm Down With Kava: What Clinicians Need to Know.
    Goldin D; Salani D
    J Psychosoc Nurs Ment Health Serv; 2022 Dec; 60(12):17-24. PubMed ID: 35763396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
    Garrett KM; Basmadjian G; Khan IA; Schaneberg BT; Seale TW
    Psychopharmacology (Berl); 2003 Oct; 170(1):33-41. PubMed ID: 12845414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava as a Clinical Nutrient: Promises and Challenges.
    Bian T; Corral P; Wang Y; Botello J; Kingston R; Daniels T; Salloum RG; Johnston E; Huo Z; Lu J; Liu AC; Xing C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33027883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.
    Lakhan SE; Vieira KF
    Nutr J; 2010 Oct; 9():42. PubMed ID: 20929532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.
    Cribb L; Sarris J; Savage KM; Byrne GJ; Metri NJ; Scholey A; Stough C; Bousman CA
    Phytother Res; 2023 Dec; 37(12):5897-5903. PubMed ID: 37767766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S; Loew D; Gaus W
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with Kava--the root to ocombat stress].
    Müller B; Komorek R
    Wien Med Wochenschr; 1999; 149(8-10):197-201. PubMed ID: 10483680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kava-kava and anxiety: growing knowledge about the efficacy and safety.
    Bilia AR; Gallon S; Vincieri FF
    Life Sci; 2002 Apr; 70(22):2581-97. PubMed ID: 12269386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging Insights: Kava's (
    Savage K; Sarris J; Hughes M; Bousman CA; Rossell S; Scholey A; Stough C; Suo C
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava.
    Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
    [No Abstract]   [Full Text] [Related]  

  • 13. Kava (Piper methysticum).
    J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
    Pittler MH; Ernst E
    J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let's Get to the Root of Ashwagandha: What Health Care Professionals Need to Know.
    Goldin D; Salani D
    J Psychosoc Nurs Ment Health Serv; 2024 Apr; 62(4):33-40. PubMed ID: 37751577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanatory attributions of anxiety and recovery in a study of kava.
    Abraham KC; Connor KM; Davidson JR
    J Altern Complement Med; 2004 Jun; 10(3):556-9. PubMed ID: 15253862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.